
Sign up to save your podcasts
Or


In this insightful discussion from the October 1, 2024 issue of JACC, researchers reveal that triglyceride-rich lipoprotein (TRL) remnants are significantly more atherogenic than LDL cholesterol, suggesting a need for updated risk assessment strategies. The study advocates for a shift towards evaluating lipoproteins on a per-particle basis, which could revolutionize the diagnosis and treatment of lipid disorders by focusing on the functional activity of these particles.
By American College of Cardiology4.2
162162 ratings
In this insightful discussion from the October 1, 2024 issue of JACC, researchers reveal that triglyceride-rich lipoprotein (TRL) remnants are significantly more atherogenic than LDL cholesterol, suggesting a need for updated risk assessment strategies. The study advocates for a shift towards evaluating lipoproteins on a per-particle basis, which could revolutionize the diagnosis and treatment of lipid disorders by focusing on the functional activity of these particles.

134 Listeners

321 Listeners

504 Listeners

906 Listeners

21 Listeners

31 Listeners

3,374 Listeners

138 Listeners

1,150 Listeners

65 Listeners

39 Listeners

194 Listeners

94 Listeners

367 Listeners

437 Listeners